PORTFOLIO

  • FIH
  • R&D
Delivery Pipeline POC Pre-IND IIT IND Phase Ⅰ Phase Ⅱ/Ⅲ
Ex vivo β-thalassemia
Sickle cell disease
In vivo Hypertriglyceridemia
Chylomicronemia
Obesity/Diabetes
Oncology
Neurodegenerative Disease
CorrectSequence Therapeutics Co., Ltd. © (2021-2025)沪ICP备2020032248号
Powered by MetInfo 7.7 ©2008-2025  mituo.cn
HOME
ABOUT
NEWS
CONTACT